Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1991 Sep-Oct;67(5):439–459.

Epidemic diseases at the New York Hospital.

W A Klein 1, G G Reader 1
PMCID: PMC1807980  PMID: 1933070

Abstract

The New York Hospital has enjoyed a long, rich history in the development of American health care. AIDS has made relevant an understanding of the failures and successes achieved during past epidemics. Innovations in disease prevention and patient care have been essential in the conquest of pestilence. However, public indifference toward the people at greatest risk for these diseases has traditionally delayed attempts to prevent significant loss of life and socioeconomic destruction.

Full text

PDF
439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLUMENFELD H. L., KILBOURNE E. D., LOURIA D. B., ROGERS D. E. Studies on influenza in the pandemic of 1957-1958. I. An epidemiologic, clinical and serologic investigation of an intrahospital epidemic, with a note on vaccination efficacy. J Clin Invest. 1959 Jan;38(1 Pt 2):199–212. doi: 10.1172/JCI103789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CLARK C. M., ELMENDORF D. F., Jr, CAWTHON W. U., MUSCHENHEIM C., MCDERMOTT W. Isoniazid (isonicotinic acid hydrazide) in the treatment of miliary and meningeal tuberculosis. Am Rev Tuberc. 1952 Oct;66(4):391–415. doi: 10.1164/art.1952.66.4.391. [DOI] [PubMed] [Google Scholar]
  3. DES PREZ R. M., MUSCHENHEIM C. The chemoprophylaxis of tuberculosis. J Chronic Dis. 1962 Jun;15:599–610. doi: 10.1016/0021-9681(62)90030-9. [DOI] [PubMed] [Google Scholar]
  4. Douglas R. G., Jr Prevention, management, and control of influenza: a mandate for the 1980s. Am J Med. 1987 Jun 19;82(6A):1–3. doi: 10.1016/0002-9343(87)90553-5. [DOI] [PubMed] [Google Scholar]
  5. KILBOURNE E. D. Studies on influenza in the pandemic of 1957-1958. III. Isolation of influenza A (Asian strain) viruses from influenza patients with pulmonary complications; details of virus isolation and characterization of isolates, with quantitative comparison of isolation methods. J Clin Invest. 1959 Jan;38(1 Pt 2):266–274. doi: 10.1172/JCI103792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. LOURIA D. B., BLUMENFELD H. L., ELLIS J. T., KILBOURNE E. D., ROGERS D. E. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest. 1959 Jan;38(1 Pt 2):213–265. doi: 10.1172/JCI103791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MCDERMOTT W. Isonicotinic acid derivatives in tuberculosis treatment; history of the development of the drugs. Trans Annu Meet Natl Tuberc Assoc. 1952;48:421–424. [PubMed] [Google Scholar]
  8. Murray H. W., Hillman J. K., Rubin B. Y., Kelly C. D., Jacobs J. L., Tyler L. W., Donelly D. M., Carriero S. M., Godbold J. H., Roberts R. B. Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. N Engl J Med. 1985 Dec 12;313(24):1504–1510. doi: 10.1056/NEJM198512123132403. [DOI] [PubMed] [Google Scholar]
  9. Murray H. W., Scavuzzo D. A., Chaparas S. D., Roberts R. B. T lymphocyte responses to mycobacterial antigen in AIDS patients with disseminated Mycobacterium avium-Mycobacterium intracellulare infection. Chest. 1988 May;93(5):922–925. doi: 10.1378/chest.93.5.922. [DOI] [PubMed] [Google Scholar]
  10. Murray H. W., Scavuzzo D., Jacobs J. L., Kaplan M. H., Libby D. M., Schindler J., Roberts R. B. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. J Immunol. 1987 Apr 15;138(8):2457–2462. [PubMed] [Google Scholar]
  11. Perry S., Jacobsen P. Neuropsychiatric manifestations of AIDS-spectrum disorders. Hosp Community Psychiatry. 1986 Feb;37(2):135–142. doi: 10.1176/ps.37.2.135. [DOI] [PubMed] [Google Scholar]
  12. Roberts R. B., Laskin O. L., Laurence J., Scavuzzo D., Murray H. W., Kim Y. T., Connor J. D. Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther. 1987 Oct;42(4):365–373. doi: 10.1038/clpt.1987.165. [DOI] [PubMed] [Google Scholar]
  13. Rogers D. E. Federal spending on AIDS--how much is enough? N Engl J Med. 1989 Jun 15;320(24):1623–1624. doi: 10.1056/NEJM198906153202411. [DOI] [PubMed] [Google Scholar]
  14. Ron A., Rogers D. E. New York City's health care crisis: AIDS, the poor, and limited resources. JAMA. 1988 Sep 9;260(10):1453–1453. [PubMed] [Google Scholar]
  15. Rosenberg C. E. What is an epidemic? AIDS in historical perspective. Daedalus. 1989 Spring;118(2):1–17. [PubMed] [Google Scholar]
  16. Soave R., Johnson W. D., Jr Cryptosporidium and Isospora belli infections. J Infect Dis. 1988 Feb;157(2):225–229. doi: 10.1093/infdis/157.2.225. [DOI] [PubMed] [Google Scholar]
  17. Stern J. J., Hartman B. J., Sharkey P., Rowland V., Squires K. E., Murray H. W., Graybill J. R. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am J Med. 1988 Oct;85(4):477–480. doi: 10.1016/s0002-9343(88)80081-0. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES